|
ECOR | Electrocore, Inc. |
|
|
ECOR | Electrocore, Inc. |
| Electromedical & Electrotherapeutic Apparatus |
| Book value per $ invested | $ 0.19 |
| Leverage | 65.86% |
| Market Cap | $ 104.5m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -12.2m |
| Margin | -46.45% |
electroCore, Inc., a commercial-stage medical device company, is dedicated to the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is headquartered in Rockaway, New Jersey.